Congenital Toxoplasmosis: The State of the Art
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Infection with the protozoan parasite Toxoplasma gondii occurs worldwide and usually causes no symptoms. However, a primary infection of pregnant women, may infect the fetus by transplacental transmission. The risk of mother-to-child transmission depends on week of pregnancy at the time of maternal infection: it is low in the first trimester, may reach 90% in the last days of pregnancy. Inversely, however, fetal disease is more severe when infection occurs early in pregnancy than later. Systematic serologic testing in pregnant women who have no antibodies at the beginning of pregnancy, can accurately reveal active maternal infection. Therefore, the risk of fetal infection should be assessed and preventive treatment with spiramycin must be introduced as soon as possible to reduce the risk of mother-to-child transmission, and the severity of fetal infection. When maternal infection is confirmed, prenatal diagnosis with Polymerase Chain Reaction (PCR) on amniotic fluid is recommended. If fetal infection is certain, the maternal treatment is changed to a combination of pyrimethamine-sulfonamide and folinic acid. Congenitally infected newborns are usually asymptomatic at birth, but at risk for tardive sequelae, such as blindness. When congenital infection is evident, disease include retinochoroiditis, cerebral calcifications, hydrocephalus, neurocognitive impairment. The diagnosis of congenital infection must be confirmed at birth and management, specific therapy, and follow-up with multidisciplinary counseling, must be guaranteed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology of and Diagnostic Strategies for Toxoplasmosis
Robert-Gangneux, F., & Dardé, M.-L. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05013-11 · Cited by 1,815 · cited 3×
“On the contrary, the increase of IgG or the appearance of IgM and/or IgA antibodies define the congenital infection (18).”
BackgroundInfluentialThe global burden of congenital toxoplasmosis: a systematic review
Torgerson, P. R., & Mastroiacovo, P. (2013) · Bulletin of the World Health Organization · doi:10.2471/blt.12.111732 · Cited by 748
Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical Practice
Dunay, I. R., Gajurel, K., Dhakal, R., Liesenfeld, O., & Montoya, J. G. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00057-17 · Cited by 553
(2007) · The Lancet · doi:10.1016/s0140-6736(07)60072-5 · Cited by 542
Infections at the maternal–fetal interface: an overview of pathogenesis and defence
Megli, C. J., & Coyne, C. B. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00610-y · Cited by 442 · cited 1×
“gondii infection through the specific induction of various cytokines and chemokines, including the robust induction of the regulatory T cell chemokine (19, 20).”
BackgroundSHWAB, E. K., ZHU, X.-Q., MAJUMDAR, D., PENA, H. F. J., GENNARI, S. M., DUBEY, J. P., & SU, C. (2014) · Parasitology · doi:10.1017/s0031182013001844 · Cited by 432 · cited 1×
“The parasite genotype may play a role in determining the severity of disease: in South America the strains show greater genetic variability and are usually much more virulent (4, 5).”
BackgroundMicrobial Vertical Transmission during Human Pregnancy
Arora, N., Sadovsky, Y., Dermody, T. S., & Coyne, C. B. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.04.007 · Cited by 382 · cited 1×
“gondii infection through the specific induction of various cytokines and chemokines, including the robust induction of the regulatory T cell chemokine (19, 20).”
BackgroundMcLeod, R., Boyer, K., Karrison, T., Kasza, K., Swisher, C., Roizen, N., Jalbrzikowski, J., Remington, J., Heydemann, P., Noble, A. G., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/501360 · Cited by 359
Ocular Sequelae of Congenital Toxoplasmosis in Brazil Compared with Europe
Gilbert, R. E., Freeman, K., Lago, E. G., Bahia-Oliveira, L. M. G., Tan, H. K., Wallon, M., Buffolano, W., Stanford, M. R., Petersen, E., & (EMSCOT), F. T. E. M. S. O. C. T. (2008) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000277 · Cited by 324 · cited 11×
“Brazilian infants developed chorioretinitis more frequently and the lesions are multiple, larger, and more likely located in the posterior pole than the European infants (24).”
BackgroundInfluentialDrugs in development for toxoplasmosis: advances, challenges, and current status
Alday, H., & Doggett, J. (2017) · Drug Design, Development and Therapy · doi:10.2147/dddt.s60973 · Cited by 321
Metadata
- Authors
- Bollani, L., Auriti, C., Achille, C., Garofoli, F., De Rose, D. U., Meroni, V., Salvatori, G., & Tzialla, C.
- Venue
- Frontiers in Pediatrics
- Publisher
- Frontiers Media SA
- Published
- 2022-07-06
- Volume
- 10
- Pages
- 894573-894573
- ISSN
- 2296-2360 (ISSN-L)
- OpenAlex
- W4286615913
- Cited by
- 176
- References
- 51
- FWCI
- 20.61
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Congenital Toxoplasmosis: The State of the Art. https://app.cochat.ai/papers/10.3389/fped.2022.894573
- The paper
- Bollani, L., Auriti, C., Achille, C., Garofoli, F., De Rose, D. U., Meroni, V., Salvatori, G., & Tzialla, C. (2022). Congenital Toxoplasmosis: The State of the Art. Frontiers in Pediatrics. https://doi.org/10.3389/fped.2022.894573
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.